TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

Clinical trial NCT00694629 · COMPLETED

Trial details

NCT number: NCT00694629
Sponsor: Centers for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2008-12-01
Primary completion: 2013-06-01
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.